Skip to content

Automated Bilingual Computerized Alcohol Screening and Intervention in Latinos (AB-CASI)

Automated Bilingual Computerized Alcohol Screen and Intervention in Latinos

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02247388
Acronym
AB-CASI
Enrollment
840
Registered
2014-09-25
Start date
2014-10-31
Completion date
2020-04-30
Last updated
2022-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Dependence

Keywords

Alcohol Dependence, Alcoholism, AB-CASI, Emergency Department

Brief summary

To study the efficacy of AB-CASI against standard of care in a randomized controlled trial in the Emergency Department.

Detailed description

The research team will rigorously test the efficacy of AB-CASI, against a standard condition (SC) in a first-of-a-kind ED randomized controlled trial. Studying an urban adult (≥ 18 y/o) Latino ED population, the objectives are to demonstrate the superiority of AB-CASI compared to SC in: 1) reduction of alcohol consumption (Aims 1), 2) reduction of negative health behaviors and consequences (Aim 2), and 3) increasing 30-day treatment engagement (Aim 3). The investigators will also explore variation of the AB-CASI intervention on alcohol consumption, alcohol-related negative health behaviors and consequences, and 30-day treatment engagement by Latino subpopulations (Puerto-Rican, Mexican-American, Cuban-American, South/Central American) as well as other potential modifiers (age, birthplace, gender, preferred language, reason for ED visit, and smoking status). English and Spanish speaking Latino adults presenting to the Bridgeport Hospital ED will be screened using the study inclusion and exclusion criteria. In March 2020, the primary and secondary outcomes were corrected to reflect the protocol as it was written initially. The citations section of this study registration also includes the citation for the published protocol manuscript.

Interventions

BEHAVIORALComputerized Alcohol Screening

iPad based automated alcohol screening

iPad based automated brief negotiated interview (BNI)

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* English and Spanish speaking adult * ≥ 18 y/o * Latino patients who present to the Bridgeport Hospital's ED * Drink over the NIAAA low-risk limits.

Exclusion criteria

* Primary language other than English or Spanish * Current enrollment in an alcohol or substance abuse treatment program * Current ED visit for acute psychosis * Condition that precludes interview or AB-CASI use i.e., life threatening injury/illness * In police custody * Inability to provide two contact numbers for follow-up

Design outcomes

Primary

MeasureTime frameDescription
Self Reported Binge Drinking Episodes12 monthsSelf reported number of binge drinking episodes over the previous 28 days assessed using the 28 day timeline follow back at 12 months. This outcome was corrected 3/2020 to accurately reflect the time frame from the original protocol.

Secondary

MeasureTime frameDescription
Mean Number of Weekly Drinks12 months post enrollmentSelf reported mean number of weekly drinks as measured by a 28 day timeline follow back. This outcome was corrected 3/2020 to accurately reflect the time frame from the original protocol. It was also moved to the secondary outcome measure section as was the original intent.
Alcohol-Related Negative Health Behaviors and Consequences: episodes of impaired drivin12 months post enrollmentSelf reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school)
Alcohol-Related Negative Health Behaviors and Consequences: episodes riding with an impaired driver12 months post enrollmentSelf reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school)
Alcohol-Related Negative Health Behaviors and Consequences: number of arrests12 months post enrollmentSelf reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school)
Alcohol-Related Negative Health Behaviors and Consequences: episodes of tardiness from work/school12 months post enrollmentSelf reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school)
Alcohol-Related Negative Health Behaviors and Consequences: days absent from work/school12 months post enrollmentSelf reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school)
Alcohol-Related Negative Health Behaviors and Consequences: number of injuries12 months post enrollmentSelf reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school)

Other

MeasureTime frameDescription
30 Day Treatment Engagement30 days post enrollmentEngagement in alcohol treatment program based on Treatment Services Review at 30 day phone follow up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026